Ghrelin-receptor research
Ipamorelin review
A human trial exists, but its surgical setting and negative efficacy result matter when assessing wellness claims.
Peptide Index is operated by the team behind Peptide Guide, a peptide vendor. Read our disclosure.
Included evidence
Human randomized trial
What was studied
Hospital patients recovering from bowel surgery received intravenous ipamorelin or placebo.
What the research found
- The selected trial found no statistically significant improvement in its key or secondary efficacy analyses.
Where the evidence stops
- This was a small postoperative study, not a test of muscle gain, sleep, or anti-aging.
- Its findings do not establish benefits or safety for other routes or prolonged use.
Safety context
FDA flags immune-response concerns and serious adverse events reported during intravenous use; other injection routes lack adequate safety information.
Educational information only. This review does not recommend self-treatment or establish that products sold online match a studied formulation. Individual medical decisions belong with a qualified clinician.
Read the sources
These are the documents included in this review. Evidence labels describe this selection; they are not effectiveness or safety scores.
This is a selected-source editorial review, not a systematic review or a claim of medical review. New findings may change the assessment.
Next editorial check due .
How these reviews are prepared